Ceramide mediates radiation-induced death of endothelium

Critical Care Medicine

Volumn 28, Issue 4 SUPPL., 2000, Pages

  Lin, Xinhua ^a   Fuks, Zvi ^a   Kolesnick, Richard ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Apoptosis; Ceramide; Ceramide synthase; Endothelium; Radiation; Sphingomyelinase

Indexed keywords

CERAMIDE; CYCLIC AMP; PHOSPHATIDYLINOSITIDE; SPHINGOMYELIN; SPHINGOSINE ACYLTRANSFERASE;

APOPTOSIS; CANCER RADIOTHERAPY; CELL DEATH; ENDOTHELIUM; HEMATOPOIETIC CELL; HUMAN; LYMPHOID CELL; NONHUMAN; PRIORITY JOURNAL; RADIATION RESPONSE; RADIOSENSITIVITY; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION;

EID: 0034014838     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200004001-00010     Document Type: Review

References (88)

1. Haimovitz-Friedman A, Kolesnick RN, Fuks Z: Ceramide signaling in apoptosis. Br Med Bull 1997; 53:615-621
2. Ellis HM, Horvitz HR: Genetic control of programmed cell death in the nematode C. elegans. Cell 1986; 44:817-829
3. Haimovitz-Friedman A, Kolesnick RN, Fuks Z: Modulation of the apoptotic response: Potential for improving the outcome in clinical radiotherapy. Semin Radiat Oncol 1996; 6:273-283
4. Vidair CA, Chen CH, Ling CC, et al: Apoptosis induced by X-irradiation of rec-myc cells is postmitotic and not predicted by the time after irradiation or behavior of sister cells. Cancer Res 1996; 56:4116-4118
5. Meyn RE, Stephens LC, Hunter NR, et al: Reemergence of apoptotic cells between fractionated doses in irradiated murine tumors. Int J Radiat Oncol Biol Phys 1994; 30: 619-624
6. Fuks Z, Persaud RS, Alfieri A, et al: Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res 1994; 54:2582-2590
7. Fuks Z, Alfieri A, Haimovitz-Friedman A, et al: Intravenous basic fibroblast growth factor protects the lung but not mediastinal organs against radiation-induced apoptosis in vivo. Cancer Journal of Scientific American 1995; 1:62-72
8. Kastan MB, Zhan Q, el-Deiry WS, et al: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 1992; 71:587-597
9. Lowe SW, Schmitt EM, Smith SW, et al: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993; 362: 847-849
10. Canman CE, Kastan MB: Induction of apoptosis by tumor suppressor genes and oncogenes. Semin Cancer Biol 1995; 6:17-25
11. Bose R, Verheij M, Haimovitz-Friedman A, et al: Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals. Cell 1995; 82:405-414
12. Santana P, Pena LA, Haimovitz-Friedman A, et al: Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 1996; 86: 189-199
13. Mathias S, Pena LA, Kolesnick RN: Signal transduction of stress via ceramide. Biochem J 1998; 335:465-480
14. Spiegel S, Foster D, Kolesnick R: Signal transduction through lipid second messengers. Curr Opin Cell Biol 1996; 8:159-167
15. Haimovitz-Friedman A, Kan CC, Ehleiter D, et al: Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med 1994; 180:525-535
16. Haimovitz-Friedman A, Balaban N, McLoughlin M, et al: Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res 1994; 54:2591-2597
17. Chmura SJ, Nodzenski E, Beckett MA, et al: Loss of ceramide production confers resistance to radiation-induced apoptosis. Cancer Res 1997; 57:1270-1275
18. Kolesnick RN: Sphingomyelin and derivatives as cellular signals. Prog Lipid Res 1991; 30:1-38
19. Merrill AH, Schmelz EM, Dillehay DL, et al: Sphingolipids - The enigmatic lipid class -Biochemistry, physiology, and pathophysiology. Toxicol Appl Pharmacol 1997; 142: 208-225
20. Spiegel S, Merrill AH: Sphingolipid metabolism and cell growth regulation. FASEB J 1996; 10:1388-1397
21. Pena LA, Fuks Z, Kolesnick R: Stress-induced apoptosis and the sphingomyelin pathway. Biochem Pharmacol 1997; 53: 615-621
22. Hannun YA: Function of ceramide in coordinating cellular reponses to stress. Science 1996; 274:1855-1859
23. Ballou LR, Laulederkind SJF, Rosloniec EF, et al: Ceramide signalling and the immune response. Biochim Biophys Acta 1996; 1301: 273-287
24. Nyberg L, Duan RD, Axelson J, et al: Identification of an alkaline sphingomyelinase activity in human bile. Biochim Biophys Acta 1996; 1300:42-48
25. Duan RD, Hertervig E, Nyberg L, et al: Distribution of alkaline sphingomyelinase activity in human beings and animals. Tissue and species differences. Dig Dis Sci 1996; 41: 1801-1806
26. Schuchman E, Desnick R: The Metabolic Basis of Inherited Disease. Scriver C, Beaudet A, Sly W, et al (Eds). New York, McGraw Hill, 1995
27. Schneider PB, Kennedy EP: Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease. J Lipid Res 1967; 8:202-209
28. Schuchman EH, Levran O, Pereira LV, et al: Structural organization and complete nucleotide sequence of the gene encoding human acid sphingomyelinase (SMPD1). Genomics 1992; 12:197-205
29. Schuchman EH, Suchi M, Takahahi T, et al: Human acid sphingomyelinase: Isolation, nucleotide sequence, and expression of the full-length and alternatively spliced cDNAs. J Biol Chem 1991; 266:8531-8539
30. Marathe S, Schissel S, Yellin M, et al: Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications for early atherogenesis and ceramide-mediated cell signaling. J Biol Chem 1998; 273:4081-4088
31. Schissel S, Keesler G, Schuchman E, et al: The cellular trafficking and zinc dependence of secretory and lysosomal sphingomyelinase, two products of the acid sphingomyelinase gene. J Biol Chem 1998; 273: 18250-18259
32. Schissel S, Jiang X, Tweedie-Hardman J, et al: Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development. J Biol Chem 1998; 273:2738-2746
33. Liu P, Anderson R: Compartmentalized production of ceramide at the cell surface. J Biol Chem 1995; 270:27179-27185
34. Schissel S, Schuchman E, Williams K, et al: Zn2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene. J Biol Chem 1996; 271:18431-18436
35. Horinouchi K, Erlich S, Perl DP, et al: Acid sphingomyelinase deficient mice: A model of types A and B Niemann-Pick disease. Nature Gen 1995; 10:288-293
36. Otterbach B, Stoffel W: Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann-Pick disease). Cell 1995; 81: 1053-1061
37. Liu B, Andrieu-Abadie N, Levade T, et al: Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death. J Biol Chem 1998; 273: 11313-11320
38. Tomiuk S, Hofmann K, Nix M, et al: Cloned mammalian neutral sphingomyelinase: Functions in sphingolipid signaling? Proc Natl Acad Sci U S A 1998; 95:3638-3643
39. Liao WC, Haimovitz-Friedman A, Persaud RS, et al: Ataxia telangiectasia-mutated gene product inhibits DNA damage-induced apoptosis via ceramide synthase. J Biol Chem 1999; 274:17908-17917
40. Bajjalieh SM, Martin TFJ, Floor E: Synaptic vesicle ceramide kinase. J Biol Chem 1989; 264:14354-14360
41. Kolesnick RN, Hemer MR: Characterization of a ceramide kinase activity from human leukemia (HL-60) cells: Separation from diacylglycerol kinase actvity. J Biol Chem 1990; 265:18803-18808
42. Lavie Y, Cao H, Bursten SL, et al: Accumulation of glucosylceramides in multidrug-resistant cancer cells. J Biol Chem 1996; 271: 19530-19536
43. Nikolova-Karakashian M, Morgan ET, Alexander C, et al: Bimodal regulation of ceramidase by interleukin-1beta. Implications for the regulation of cytochrome p450 2C11. J Biol Chem 1997; 272:18718-18724
44. Hannun YA: Apoptosis and the dilemma of cancer chemotherapy. Blood 1997; 89: 1845-1853
45. Dickson R, Nagiec E, Skrzypek M, et al: Sphingolipids are potential heat stress signals in Saccharomyces. J Biol Chem 1997; 272:30196-30200
46. Jenkins G, Richards A, Wahl T, et al: Involvement of yeast sphingolipids in the heat stress response of Saccharomyces cerevisiae. J Biol Chem 1997; 272:32566-32572
47. Mandala S, Thornton R, Tu Z, et al: Sphingoid base 1-phosphate phosphatase: A key regulator of sphingolipid metabolism and stress response. Proc Natl Acad Sci U S A 1998; 95:150-155
48. Wells G, Dickson R, Lester R: Heat-induced elevation of ceramide in Saccharomyces cerevisiae via de novo synthesis. J Biol Chem 1998; 273:7235-7243
49. Quintans J, Kilkus J, McShan C, et al: Ceramide mediates the apoptotic response of WEHI 231 cells to anti-immunoglobulin, corticosteroids and irradiation. Biochem Biophys Res Comm 1994; 202:710-714
50. Chmura S, Mauceri H, Advani S, et al: Decreasing the apoptotic threshold of tumor cells through protein kinase C inhibition and sphingomyelinase activation increases tumor killing by ionizing radiation. Cancer Res 1997; 57:4340-4347
51. Herr I, Wilhelm D, Bohler T, et al: Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J 1997; 16:6200-6208
52. Michael JM, Lavin MF, Watters DJ: Resistance to radiation-induced apoptosis in Burkitt's lymphoma cells is associated with defective ceramide signaling. Cancer Res 1997; 57:3600-3605
53. Bruno AP, Laurent G, Averbeck D, et al: Lack of ceramide generation in TF-1 human myeloid leukemic cells resistant to ionizing radiation. Cell Death Diff 1998; 5:172-182
54. Kelly ML, Tang Y, Rosensweig N, et al: Granulocyte-macrophage colony-stimulating factor rescues TF-1 leukemia cells from ionizing radiation-induced apoptosis through a pathway mediated by protein kinase Calpha. Blood 1998; 92:416-424
55. Zundel W, Giaccia A: Inhibition of the anti-apoptotic PI(3)K/Akt/Bad pathway by stress. Genes Dev 1998; 12:1941-1946
56. Dbaibo GS, Pushkareva MY, Rachid RA, et al: p53-dependent ceramide response to genotoxic stress. J Clin Invest 1998; 102:329-339
57. Kimura K, Bowen C, Spiegel S, et al: Tumor necrosis factor-alpha sensitizes prostate cancer cells to gamma-irradiation-induced apoptosis. Cancer Res 1999; 59:1606-1614
58. Tepper AD, de Vries E, van Blitterswijk WJ, et al: Ordering of ceramide formation, caspase activation, and mitochondrial changes during CD95- and DNA damage-induced apoptosis. J Clin Invest 1999; 103:971-978
59. Boesen-de Cock JG, Tepper AD, de Vries E, et al: Common regulation of apoptosis signaling induced by CD95 and the DNA-damaging stimuli etoposide and gamma-radiation downstream from caspase-8 activation. J Biol Chem 1999; 274:14255-14261
60. Verheij M, Bose R, Lin XH, et al: Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996; 380:75-79
61. Dbaibo GS, Perry DK, Gamard CJ, et al: Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-alpha: CrmA and Bcl-2 target distinct components in the apoptotic pathway. J Exp Med 1997; 185:481-490
62. Zhang J, Alter N, Reed JC, et al: Bcl-2 interrupts the ceramide-mediated pathway of cell death. Proc Natl Acad Sci U S A 1996; 93: 5325-5328
63. Martin SJ, Newmeyer DD, Mathias S, et al: Cell-free reconstitution of Fas-, UV radiation- and ceramide-induced apoptosis. EMBO J 1995; 14:5191-5200
64. Decaudin D, Geley S, Hirsch T, et al: Bcl-2 and Bel-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res 1997; 57:62-67
65. Geley S, Hartmann BL, Kofler R: Ceramides induce a form of apoptosis in human acute lymphoblastic leukemia cells that is inhibited by Bcl-2, but not by CrmA. FEBS Lett 1997; 400:15-18
66. Smyth MJ, Perry DK, Zhang J, et al: prICE: A downstream target for ceramide-induced apoptosis and for the inhibitory action of Bcl-2. Biochem J 1996; 316:25-28
67. Susin SA, Zamzami N, Castedo M, et al: Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med 1996; 184: 1331-1341
68. Susin S, Zamzami N, Larochette N, et al: A cytofluorometric assay of nuclear apoptosis induced in a cell-free system: Application to ceramide-induced apoptosis. Exp Cell Res 1997; 236:397-403
69. Srinivasan A, Foster LM, Testa MP, et al: Bcl-2 expression in neural cells blocks activation of ICE/CED-3 family proteases during apoptosis. J Neurosci 1996; 16:5654-5660
70. Haimovitz-Friedman A, Cordon-Cardo C, Bayoumy S, et al: Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med 1997; 186:1831-1841
71. Ward JF: The complexity of DNA damage: Relevance to biological consequences. Int J Radiat Biol 1994; 66:427-432
72. Chmura SJ, Nodzenski E, Crane MA, et al: Cross-talk between ceramide and PKC activity in the control of apoptosis in WEHI-231. Adv Exp Med Biol 1996; 406:39-55
73. Santana P, Lianes L, Hernandez I, et al: Ceramide mediates tumor necrosis factor effects on P450-aromatase activity in cultured granulosa cells. Endocrinology 1995; 136: 2345-2348
74. Allan-Yorke J, Record M, De Preval C, et al: Distinct pathways for tumor necrosis factor alpha and ceramides in human cytomegalovirus infection. J Virol 1998; 72:2316-2322
75. Chmura SJ, Nodzenski E, Weichselbaum RR, et al: Protein kinase C inhibition induces apoptosis and ceramide production through activation of a neutral sphingomyelinase. Cancer Res 1996; 56:2711-2714
76. Hallahan DE, Virudachalam S, Schwartz JL, et al: Inhibition of protein kinases sensitizes human tumor cells to ionizing radiation. Radiat Res 1992; 29:345-350
77. Hallahan D, Virudachalam S, Sherman M, et al: Tumor necrosis factor gene expression is mediated by protein kinase C following activation by ionizing radiation. Cancer Res 1991; 51:4565-4569
78. Hallahan DE, Virudachalam S, Grdina D, et al: The isoquinoline sulfonamide H7 attenuates radiation-mediated protein kinase C activation and delays the onset of x-ray-induced G2 arrest. M J Radiat Oncol Biol Phys 1992; 24:687-692
79. Uckun FM, Schieven GL, Tuel-Ahlgren L, et al: Tyrosine phosphorylation is a mandatory proximal step in radiation-induced activation of the protein kinase C signaling pathway in human B-lymphocyte precursors. Proc Natl Acad Sci U S A 1993; 90:252-256
80. Mansat V, Laurent G, Levade T, et al: The protein kinase C activators phorbol esters and phosphatidylserine inhibit neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin. Cancer Res 1997; 57:5300-5304
81. Strum JC, Small GW, Pauig SB. et al: 1-B-D-arabinofuranosylcytosine stimulates ceramide and diglyceride formation in HL-60 cells. J Biol Chem 1994; 269:15493-15497
82. Whitman SP, Civoli F, Daniel LW: Protein kinase CbetaII activation by 1-beta-D-arabinofuranosylcytosine is antagonistic to stimulation of apoptosis and Bcl-2 alpha down-regulation. J Biol Chem 1997; 272: 23481-23484
83. Huwiler A, Pfeilschifter J, van den Bosch H: Nitric oxide donors induce stress signaling via ceramide formation in rat renal mesangial cells. J Biol Chem 1999; 274:7190-7195
84. Spiegel S: Sphingosine 1-phosphate: A prototype of a new class of second messengers. J Leukoc Biol 1999; 65:341-344
85. Cuvillier O, Pirianov G, Kleuser B, et al: Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 1996; 381:800-803
86. Lucci A, Cho WI, Han TY, et al: Glucosylceramide: A marker for multiple-drug resistant cancers. Anticancer Res 1998; 18:475-480
87. Bieberich E, Freischutz B, Suzuki M, et al: Differential effects of glycolipid biosynthesis inhibitors on ceramide-induced cell death in neuroblastoma cells. J Neurochem 1999; 72: 1040-1049
88. Lavie Y, Cao H, Volner A, et al: Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells. J Biol Chem 1997; 272:1682-1687